Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Steve L Hass"'
Autor:
Jenny Zhou, Xinglei Chai, Rajeev Ayyagari, Eric Q. Wu, Steve L Hass, Sarah M Donelson, Shengsheng Yu, Stephen A Tilles, Jun Liu, Dan Robison, Alex Smith
Publikováno v:
Advances in Therapy
Introduction The phase 3 trial PALISADE, comparing peanut (Arachis hypogaea) allergen powder-dnfp (PTAH) oral immunotherapy versus placebo in peanut-allergic children, reported that a significantly higher percentage of PTAH-treated participants toler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79210f0b7c1decaa240b9a0febb5f8a1
http://europepmc.org/articles/PMC8264172
http://europepmc.org/articles/PMC8264172
Autor:
Steve L Hass, Shengsheng Yu, Michael S. Blaiss, Kevin Norrett, Annie Guerin, Dominick Latremouille-Viau, Dan Robison, Stephen A Tilles, J. Allen Meadows
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 27:516-527
BACKGROUND: The economic burden of food allergy is large; however, costs specific to individuals with peanut allergy experiencing reactions to peanuts remain to be evaluated. As the prevalence of peanut allergy continues to increase in children, a be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c2c5b67ead7ac4ee9e378434f192b26
https://doi.org/10.18553/jmcp.2021.20389
https://doi.org/10.18553/jmcp.2021.20389
Autor:
Annie Guerin, J. Allen Meadows, Stephen A Tilles, Steve L Hass, Dominick Latremouille-Viau, Shengsheng Yu
Publikováno v:
Allergy and asthma proceedings. 42(4)
Background: Until recently, the standard approach to care for individuals with peanut allergy (PA) was limited to allergen avoidance and treatment of reactions with emergency medicines. Objectives: To assess health-care resource utilization (HRU) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8590a2136a2e758d312ad1a399488c3
https://pubmed.ncbi.nlm.nih.gov/34187618
https://pubmed.ncbi.nlm.nih.gov/34187618